OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0910-AF69 View EO 12866 Meetings | Received Date: 01/17/2015 |
Title: Over-the-Counter (OTC) Drug Review--Topical Antimicrobial Drug Products | |
Agency/Subagency: HHS / FDA | Stage: Proposed Rule |
Concluded Action: Consistent with Change | Concluded Date: 04/27/2015 |
Section 3(f)(1) Significant *: No | |
Legal Deadline: None | Economically Significant **: Yes |
Publication Date: 05/01/2015 | Unfunded Mandates: Private Sector |
Major: Yes | Related To Homeland Security: No |
Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
Federalism Implications: Yes | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: Uncollected | |
|